Muhammad Irfan Alam

Muhammad Irfan Alam is a Research Fellow at the University of Sunderland specializing in pharmaceutical drug delivery systems. His research focuses on developing advanced liposomal and microparticle formulations for targeted antibiotic therapy against Helicobacter pylori infections, with significant contributions to furazolidone-based treatments.

His educational background includes:

• PhD in Pharmaceutical Sciences, University of Sunderland (2017)

Dr. Alam's work centers on nanotechnology-driven drug delivery, particularly optimizing chitosan-based microparticles and liposomal carriers for gastrointestinal applications. He investigates mucin adhesion properties, controlled drug release mechanisms, and combinatorial approaches using agents like N-Acetyl Cysteine to enhance antibacterial efficacy. His research addresses critical challenges in antibiotic resistance and gastric drug delivery limitations.

Publication trends show sustained focus on furazolidone delivery systems since 2016, with recent work (2024) demonstrating innovative augmented therapy approaches. His research spans pharmaceutical formulation, materials science, and translational antibacterial development, consistently targeting improved treatment outcomes for gastrointestinal infections.

Current research activity is evidenced by the 2024 Pharmaceutics publication, indicating ongoing projects and likely grant funding. Dr. Alam maintains international collaborations, as seen in his multi-institutional 2024 paper, suggesting strong networking within the pharmaceutical research community.

As a post-PhD researcher, Dr. Alam contributes to the University of Sunderland's pharmaceutical sciences capabilities through experimental drug delivery research, focusing on practical solutions for antibiotic resistance challenges in clinical settings.